How are drug development and clinical trials changing?
When to use bispecifics for AML
ECHELON-1 trial data from ASH 2017: controversies and clinical translation
Current standard of care for patients who are eligible for autologous stem cell transplantation
Virus-specific T cells - effectiveness, safety profile and use